Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation

Background. Primary cutaneous T-cell lymphomas are rare heterogeneous group of lymphoproliferative diseases characterized by primarily involving skin and subcutaneous adipose tissue. Half of these cases are mycosis fungoides (MF), for about 25% are cutaneous CD30+ lymphoproliferative diseases (CD30+...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liliya G. Gorenkova, Irena E. Belousova, Sergei K. Kravchenko, Alla M. Kovrigina, Yulia V. Sidorova, Nataliya V. Ryzhikova, Elena E. Lepik, Tatiana V. Shneyder
Formato:	article
Lenguaje:	RU
Publicado:	IP Habib O.N. 2021
Materias:	primary t-cell lymphomas of the skin targeted therapy brentuximab vedotin Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/291b30b07346424bbc06b3d2d3266eb0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation

Ejemplares similares